Similar Perceptions on Continuous Glucose Monitor Use amongst Youth with Type 1 and Type 2 Diabetes
Authors' conclusion
Youth with T1D and T2D on insulin therapy report similar perspectives on continuous glucose monitor use and QoL measures. Insulin use in both T1D and T2D may carry a similar burden of management, and CGM may help improve quality of life.
Study context
- Population
- Youth with T1D and T2D on insulin therapy without current CGM, starting CGM intervention; T1D: 65.4% male, median age 14.2 years, median HbA1c 10.3%; T2D: 39% male, median age 16.2 years, median HbA1c 10.3%
- Participants
- 26 vs 41
- Exposure
- Youth with T1D vs T2D on insulin therapy
- T1Dn = 26
- T2Dn = 41
- Outcome
- Perceptions of CGM use (BenCGM, BurCGM questionnaires) and diabetes-related QoL (DDS) at start of CGM
- Follow-up
- Start of CGM intervention
Methodological detailsquestionnaire-based, multivariable analysis
- Questionnaire-based
- Multivariable analysis
Main finding
As reported in the abstract
BenCGM, BurCGM and DDS survey scores
- T1D and T2D scored similarly on the BenCGM, BurCGM and DDS surveys
Observational data: associations, not effects.
Further findings
Survey results by race/ethnicity (pooled T1D and T2D)
- No difference in survey results by race/ethnicity
Diabetes-related distress by sex (pooled T1D and T2D)
- Female youth had increased odds of diabetes-related distress, specifically regimen-related distress
Original publication
Similar Perceptions on Continuous Glucose Monitor Use amongst Youth with Type 1 and Type 2 Diabetes. Pediatr Diabetes. Published 19 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →